Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Noad

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
ISRN Microbiology|June 14, 2013
Use of bacterial artificial chromosomes in baculovirus research and recombinant protein expression: current trends and future perspectivesPolly Roy, Rob Noad
Human Vaccines|April 29, 2008
Virus-like particles as a vaccine delivery system: myths and factsPolly Roy, Rob Noad
Advances in Experimental Medicine and Biology|January 5, 2010
Virus-like particles as a vaccine delivery system: myths and factsPolly Roy, Rob Noad
Trends in Microbiology|September 19, 2003
Virus-like particles as immunogensRob Noad, Polly Roy
Journal of Virology|March 3, 2004
Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cellsEduardo Mortola, Rob Noad, Polly Roy
Journal of Virology|March 30, 2004
Purified recombinant bluetongue virus VP1 exhibits RNA replicase activityMark Boyce, Josa Wehrfritz, Rob Noad, et al.
The Veterinary Record|February 27, 2021
Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?Andrew N Rycroft, Ken C Smith, Rob Noad, et al.
Virology|July 29, 2006
Specific binding of Bluetongue virus NS2 to different viral plus-strand RNAsKostas Lymperopoulos, Rob Noad, Sara Tosi, et al.
The Onderstepoort Journal of Veterinary Research|November 13, 2019
Rift Valley fever virus in small ruminants in the Democratic Republic of the CongoGeorges M Tshilenge, Mfumu L K Mulumba, Gerald Misinzo, et al.
Virology Journal|September 29, 2009
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody bindingDavid J Allen, Rob Noad, Dhan Samuel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
ISRN Microbiology|June 14, 2013
Use of bacterial artificial chromosomes in baculovirus research and recombinant protein expression: current trends and future perspectivesPolly Roy, Rob Noad
Human Vaccines|April 29, 2008
Virus-like particles as a vaccine delivery system: myths and factsPolly Roy, Rob Noad
Advances in Experimental Medicine and Biology|January 5, 2010
Virus-like particles as a vaccine delivery system: myths and factsPolly Roy, Rob Noad
Trends in Microbiology|September 19, 2003
Virus-like particles as immunogensRob Noad, Polly Roy
Journal of Virology|March 3, 2004
Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cellsEduardo Mortola, Rob Noad, Polly Roy
Journal of Virology|March 30, 2004
Purified recombinant bluetongue virus VP1 exhibits RNA replicase activityMark Boyce, Josa Wehrfritz, Rob Noad, et al.
The Veterinary Record|February 27, 2021
Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?Andrew N Rycroft, Ken C Smith, Rob Noad, et al.
Virology|July 29, 2006
Specific binding of Bluetongue virus NS2 to different viral plus-strand RNAsKostas Lymperopoulos, Rob Noad, Sara Tosi, et al.
The Onderstepoort Journal of Veterinary Research|November 13, 2019
Rift Valley fever virus in small ruminants in the Democratic Republic of the CongoGeorges M Tshilenge, Mfumu L K Mulumba, Gerald Misinzo, et al.
Virology Journal|September 29, 2009
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody bindingDavid J Allen, Rob Noad, Dhan Samuel, et al.
Pageof 2